Quarterly report · Q3

Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥675.7bn2023-04-01 → 2023-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥239.1bn2023-10-01 → 2023-12-31dCons.Revenue IFRS (5-year summary)
Revenue¥881.9bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥641.5bn2022-04-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥224.5bn2022-10-01 → 2022-12-31dCons.Revenue IFRS (5-year summary)
Operating income¥39.0bn2023-04-01 → 2023-12-31Cons.Operating profit loss IFRS
Operating income¥34.2bn2023-10-01 → 2023-12-31dCons.Operating profit loss IFRS
Operating income¥142.6bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥49.0bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Profit before tax¥33.0bn2023-04-01 → 2023-12-31Cons.Profit loss before tax IFRS
Profit before tax¥34.0bn2023-10-01 → 2023-12-31dCons.Profit loss before tax IFRS
Profit before tax¥182.3bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥139.4bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥50.0bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥235.2bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥18.9bn2023-10-01 → 2023-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥143.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥108.2bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥41.4bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥235.6bn2023-04-01 → 2023-12-31Cons.Profit loss IFRS
Net income¥18.9bn2023-10-01 → 2023-12-31dCons.Profit loss IFRS
Net income¥108.4bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥41.4bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Total assets¥1.47Tat 2023-12-31Cons.Assets IFRS
Total assets¥1.51Tat 2023-03-31Cons.Assets IFRS
Total assets¥1.39Tat 2022-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥718.2bnat 2023-12-31Cons.Liabilities IFRS
Total liabilities¥867.5bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥749.9bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥641.2bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥605.6bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥511.4bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥749.9bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥640.1bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥604.5bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥348.6bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥169.3bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥205.5bnat 2023-03-31Cons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥211.3bnat 2022-12-31Cons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow−¥12.9bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥98.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥54.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥391.4bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥58.4bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥37.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥240.8bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥143.2bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥112.4bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥191.592023-04-01 → 2023-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥15.842023-10-01 → 2023-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥113.222022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥85.122022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥32.642022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥191.152023-04-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥15.812023-10-01 → 2023-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥113.082022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥85.042022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥32.62022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio51.1%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio42.4%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.4%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥29.3bn
jpcrp040300-q3r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2023-04-01 → 2023-12-31¥83.6bn
jpcrp040300-q3r_E02272-000Otherreportable segmentsegment profit2023-04-01 → 2023-12-31¥971m
jpcrp040300-q3r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2023-04-01 → 2023-12-31−¥16.2bn
—segment totalsegment profit2023-04-01 → 2023-12-31¥68.4bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥15.3bn
jpcrp040300-q3r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2022-04-01 → 2022-12-31¥110.7bn
jpcrp040300-q3r_E02272-000Otherreportable segmentsegment profit2022-04-01 → 2022-12-31−¥917m
jpcrp040300-q3r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2022-04-01 → 2022-12-31¥48.1bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥157.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 747
ItemContextValueUnit
Cash and cash equivalents IFRS (5-year summary)Prior1YearInstant205512000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1266178700
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1266178700
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant1266178700
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant1266178700
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember44638700
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember1221326400
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember12213264
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember213600
Number of shares issued shares voting rightsCurrentQuarterInstant1266178700
Number of voting rights issued shares voting rightsCurrentQuarterInstant12213264
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member44638700
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member44638700
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0353
Number of shares held in own name treasury shares etcCurrentQuarterInstant44638700
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant44638700
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0353
Cash and cash equivalents IFRSPrior1YearInstant169329000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant348572000000JPY
Trade and other receivables ca IFRSPrior1YearInstant174672000000JPY
Trade and other receivables ca IFRSCurrentQuarterInstant165268000000JPY
Other financial assets ca IFRSPrior1YearInstant11360000000JPY
Other financial assets ca IFRSCurrentQuarterInstant28783000000JPY
Inventories ca IFRSPrior1YearInstant162994000000JPY
Inventories ca IFRSCurrentQuarterInstant186517000000JPY
Income taxes receivable ca IFRSPrior1YearInstant15960000000JPY
Income taxes receivable ca IFRSCurrentQuarterInstant31063000000JPY
Other current assets ca IFRSPrior1YearInstant22421000000JPY
Other current assets ca IFRSCurrentQuarterInstant27937000000JPY
Current assets other than assets held for sale ca IFRSPrior1YearInstant556736000000JPY
Current assets other than assets held for sale ca IFRSCurrentQuarterInstant788140000000JPY
Assets held for sale IFRSPrior1YearInstant169621000000JPY
Assets held for sale IFRSCurrentQuarterInstant-JPY
Current assets IFRSPrior1YearInstant726357000000JPY
Current assets IFRSCurrentQuarterInstant788140000000JPY
Property plant and equipment IFRSPrior1YearInstant238731000000JPY
Property plant and equipment IFRSCurrentQuarterInstant249417000000JPY
Goodwill IFRSPrior1YearInstant181324000000JPY
Goodwill IFRSCurrentQuarterInstant172816000000JPY
Intangible assets IFRSPrior1YearInstant116757000000JPY
Intangible assets IFRSCurrentQuarterInstant99222000000JPY
Retirement benefit asset nca IFRSPrior1YearInstant27028000000JPY
Retirement benefit asset nca IFRSCurrentQuarterInstant28370000000JPY
Investments accounted for using equity method IFRSPrior1YearInstant1010000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass